BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 12, 2019
View Archived Issues
Secretome spills tumors' secrets
Read More
Hearing loss gene therapy works in adult mice
Read More
Dengue antibodies promote Zika-induced microcephaly
Read More
OKYO Pharma and collaborators report in vivo data for OKYO-0101 in dry eye murine model
Read More
Inflazome patents new NLRP3 inflammasome inhibitors
Read More
Boehringer Ingelheim presents promising data from proof-of-concept trial of BI-655130
Read More
AbbVie presents Mcl-1 inhibitors
Read More
Shanghai Ennova Biopharmaceutical identifies PD-1/PD-L1 interaction inhibitors
Read More
Allergan presents phase I/II results for bimatoprost sustained-release implants
Read More
Novel gene therapy prevents the onset of retinal degeneration in vivo
Read More
University of Toledo describes new HDAC inhibitors
Read More
Patient enrollment ongoing in phase II study of VRP-HER2 vaccine plus pembrolizumab
Read More
Promising interim data reported from first cohort of SUNRISE-PD study of AXO-Lenti-PD
Read More
ACADIA Pharmaceuticals divulges 5-HT2A receptor ligands
Read More
Extended evaluation phase findings from SONICS study of Recorlev in endogenous Cushing's syndrome
Read More
Characterization of novel negative allosteric modulators of metabotropic glutamate mGlu5 receptor
Read More
Steroidogenic 17beta-HSD2 inhibition for targeted intracrine therapy in bone fracture healing
Read More
Phase II results of TOL-463 for the treatment of bacterial vaginosis and vulvovaginal candidiasis
Read More
Mutations in TONSL, a fundamental DNA repair protein, cause SPONASTRIME dysplasia
Read More
Phase IIb FLUTE study of APT-1011 in eosinophilic esophagitis meets primary endpoint
Read More
Bridge Medicines signs agreement with Weill Cornell Medicine to develop novel S1P receptor modulator
Read More
CKAP4 unveiled as a new therapeutic target for PDAC
Read More
Phase III trials of vadadustat in Japanese patients with anemia due to CKD meet primary endpoint
Read More
Seres and AstraZeneca collaborate to study use of microbiome therapeutics in immuno-oncology
Read More
Axovant reports 3-month data on patient with infantile Tay-Sachs disease treated with AXO-AAV-GM2
Read More
FDA approves Dupixent for use in adolescents with moderate to severe atopic dermatitis
Read More